Oncolytics Biotech Inc. | Balance Sheet
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
27,222.00
16,184.50
26,077.30
14,123.10
11,836.10
13,699.90
Total Accounts Receivable
105.90
191.80
340.10
54.40
4,804.80
51.70
Other Current Assets
361.70
291.60
506.70
260.80
1,176.10
701
Total Current Assets
27,689.60
16,667.80
26,924.00
14,438.30
17,817.00
14,452.50
Net Property, Plant & Equipment
532.50
525.40
459.80
320.00
333.40
412.70
Total Assets
28,222.00
17,193.20
27,383.80
14,758.30
18,150.40
14,865.30
Accounts Payable
6,008.70
-
-
-
-
Other Current Liabilities
-
3,374.00
2,709.50
4,068.70
5,229.70
Total Current Liabilities
6,008.70
3,374.00
2,709.50
4,068.70
5,229.70
Other Liabilities
-
-
-
-
4,636.90
Total Liabilities
6,008.70
3,374.00
2,709.50
4,068.70
9,866.60
Common Equity (Total)
22,213.40
13,819.20
24,674.30
10,689.60
8,283.80
Total Shareholders' Equity
22,213.40
13,819.20
24,674.30
10,689.60
8,283.80
Total Equity
22,213.40
13,819.20
24,674.30
10,689.60
8,283.80
Liabilities & Shareholders' Equity
28,222.00
17,193.20
27,383.80
14,758.30
18,150.40
About Oncolytics Biotech
View Profile